PS03. Liquid Biopsy

FRIDAY, NOVEMBER 16, 08:30 ~ 10:10 | Crystal Ballroom

  • Tae-You Kim Korea

    Seoul National University Hospital

  • Ryan Dittamore USA

    Epic Sciences

  • 8:30 ~ 8:55

    Monitoring treatment response and progression in cancer patients with circulating tumor DNA sequencing

    Woong-Yang Park Korea

    Samsung Medical Center

  • 8:55 ~ 9:20

    Clinical validation of single CTC profiling as a predictive biomarker of treatment selection in mCRPC

    Ryan Dittamore USA

    Epic Sciences

    CV
  • 9:20 ~ 9:45

    Technology perspectives of liquid biopsy

    Duhee Bang Korea

    Yonsei University

    CV
  • 9:45 ~ 10:10

    Plasma circulating tumor DNA predicts therapy outcomes in advanced prostate cancer

    Alexander W.Wyatt Canada

    Vancouver Prostate Centre, University of British Columbia

    CV

Keynote Lecture

FRIDAY, NOVEMBER 16, 10:40 ~ 11:20 | Crystal Ballroom

  • Tae-You Kim Korea

    Seoul National University Hospital

  • 10:40 ~ 11:20

    Clinical trials in the era of precision medicine

    Yung-Jue Bang Korea

    Seoul National University College of Medicine

    CV

Luncheon Symposium 4(Roche Korea)

FRIDAY, NOVEMBER 16, 11:20 ~ 11:50 | Crystal Ballroom

  • Ki Hyeong Lee Korea

    Chungbuk National University College of Medicine

  • 11:20 ~ 12:00

    Targeting VEGF in the era of cancer immunotherapy

    Ji-Youn Han Korea

    National Cancer Center

    CV

Luncheon Symposium 5(Amgen Korea)

FRIDAY, NOVEMBER 16, 11:20 ~ 12:00 | Emerald Room

  • Jin Seok Ahn Korea

    Samsung Medical Center

  • 11:20 ~ 12:00

    RANKL inhibition as a treatment option in preventing skeletal-related events in cancer patients with bone metastases

    Alison T. Stopeck USA

    University of Arizona Cancer Center

    CV

Luncheon Symposium 6(Sanofi Genzyme)

FRIDAY, NOVEMBER 16, 11:20 ~ 12:00 | Sapphire Room

  • Jong Gwang Kim Korea

    Kyungpook National University School of Medicine

  • 11:20 ~ 12:00

    Expanding the horizons in treatment of mCRC: How to choose the "right" second-line

    Kei Muro Japan

    Aichi Cancer Center Hospital

    CV

Special Lecture 2

FRIDAY, NOVEMBER 16, 12:00 ~ 13:00 | Crystal Ballroom

  • Jin-Hyoung Kang Korea

    The Catholic University of Korea

  • 12:00 ~ 13:00

    Building a clinico-genomic database to inform cancer immunotherapy treatment

    Geoff Otto USA

    Foundation Medicine

    CV

PS04. Novel Technologies

FRIDAY, NOVEMBER 16, 13:00 ~ 14:40 | Crystal Ballroom

  • Seock-Ah Im Korea

    Seoul National University College of Medicine

  • William C. Hahn USA

    Dana-Farber Cancer Insitute

  • 13:00 ~ 13:25

    Computational inference of cancer dependencies in clinical samples

    Jung Kyoon Choi Korea

    KAIST

    CV
  • 13:25 ~ 13:50

    Lineage Plasticity in Prostate Cancer

    Charles L. Sawyers USA

    Memorial Sloan Kettering Cancer Center

  • 13:50 ~ 14:15

    Architecture of genomic rearrangements molding fusion oncogenes in lung adenocarcinomas

    Young Seok Ju Korea

    KAIST

    CV
  • 14:15 ~ 14:40

    Defining a cancer dependencies map

    William C. Hahn USA

    Dana-Farber Cancer Insitute

    CV

PS05. Immunology: Biomarkers and Therapies

FRIDAY, NOVEMBER 16, 15:00 ~ 16:40 | Crystal Ballroom

  • Hyunsook Lee Korea

    Seoul National University College of Natural Sciences

  • Zemin Zhang China

    Peking University

  • 15:00 ~ 15:25

    Effective biomarker for immune-precision treatment of metastatic gastric cancer

    Sun Young Rha Korea

    Yonsei University College of Medicine

    CV
  • 15:25 ~ 15:50

    Comparative analysis of tumor-infiltrating T cells across multiple tumor indications

    Zemin Zhang China

    Peking University

    CV
  • 15:50 ~ 16:15

    Advancement in anti-PD-1 therapy: Prediction and combination

    Eui-Cheol Shin Korea

    KAIST

  • 16:15 ~ 16:40

    Role of regulatory T cells in immuno-oncology.

    Hiroyoshi Nishikawa Japan

    National Cancer Center

    CV

Spotlight on Proffered Papers Session 2

FRIDAY, NOVEMBER 16, 16:40 ~ 17:10 | Crystal Ballroom

  • Jeeyun Lee Korea

    Sungkyunkwan University Samsung Medical Center

  • Sohrab Shah USA

    Memorial Sloan Kettering Cancer Center

  • 16:40 ~ 16:50

    Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy

    Joo Sang Lee USA

    Cancer Data Science Lab, National Cancer Institute, National Institute of Health, Bethesda, MD, USA

  • 16:50 ~ 17:00

    Myeloid-derived suppressor cells impair the anti-tumor activity of PD-1 blockade in gastric cancer

    Woosook Kim USA

    Columbia University

  • 17:00 ~ 17:10

    Humanized N-cadherin monoclonal antibodies demonstrate efficacy in treatment of castration resistant prostate cancer

    Evelyn Kono USA

    David Geffen School of Medicine at UCLA

Poster Session 2

FRIDAY, NOVEMBER 16, 17:15 ~ 19:30 | Sapphire Room